[The results of ovarian cancer therapy in the Hungarian Centers in 2002-2003].
Authors presented data of treatment results and course of disease in 487 ovarian cancer patients treated by primary surgery and paclitaxel-carboplatin combination chemotherapy between July 1, 2002 and December 31, 2003.


METHODS
Most of our patients (87.8%) belonged to the age-group between 40-70 years. Distribution of their histological diagnosis was as 69.6% serous, 10.7% mucinous, 5.1% endometrial and 4.7% undifferentiated carcinoma. The grade distribution was found as 8.4% grade 1, 40.9% grade 2 and 35.9% grade 3.


RESULTS
The primary surgery was evaluated as optimal in 41.7%, suboptimal in 37.3% and exploration was performed in 21.1%. Most patients started chemotherapy 20 days after surgery and 74.2% of them got six courses. During the evaluation period 61 intervallum laparotomies were performed, and resulted on 55.7% optimal debulking. Complete remission was found in 58.9%, and partial remission in 14.7% of patients. This treatment resulted on a complete remission in 40.9% at the follow-up of 12 months.
Pulay
Tamás
T
Baki
Márta
M
Bodoky
György
G
Dank
Magdolna
M
Cseh
József
J
Csejtei
András
A
Csömör
Sándor
S
Erfán
József
J
Esik
Olga
O
Faluhelyi
Zsolt
Z
Izsó
József
J
Hernádi
Zoltán
Z
Kammerer
Kinga
K
Magyar
Tamás
T
Mayer
Arpád
A
Megyery
Eva
E
Moskovits
Katalin
K
Pécsi
Lajos
L
Pikó
Béla
B
Pintér
Tamás
T
Ruzsa
Agnes
A
Szánthó
András
A
Szántó
István
I
Szántó
János
J
Szucs
Miklós
M
Tálos
Zsuzsanna
Z
Thurzó
László
L
Kásler
Miklós
M
D002288:Adenocarcinoma, Mucinous / Q000628:therapy; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001948:Brenner Tumor / Q000628:therapy; D016190:Carboplatin / Q000008:administration & dosage; D002277:Carcinoma / Q000188:drug therapy / Q000453:epidemiology / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D018269:Carcinoma, Endometrioid / Q000628:therapy; D017024:Chemotherapy, Adjuvant; D018284:Cystadenocarcinoma, Serous / Q000628:therapy; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D006814:Hungary / Q000453:epidemiology; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000453:epidemiology / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D010052:Ovariectomy; D017239:Paclitaxel / Q000008:administration & dosage; D012189:Retrospective Studies; D016896:Treatment Outcome
D016190:Carboplatin; D017239:Paclitaxel